i disagree. The real price movement will come when an interested party takes our product and joins us to work up their drug candidate.(platform validation) or we get further thru a clinical trial( and we haven’t started yet). Anyone reading our stuff that will buy into it needs all the guff in precise form or they will also just gloss over our releases as not worthy.
Given that similar companies just a little further along in the process are worth around 1-1.5BUS$ it wont be long until we get a rerate. When I say long I think end of phase 1 trials would be the latest( about 1 year off) and earlier the cns candidate being named or second eye candidate excite the market ( next 6 months).
And there is the brokers report which I have eluded to (next 3 months).
And it would help if the general biotech market would have an up phase not a down phase ( next 12 months hopefully).
At least one fish bought about 3 million this week.
PYC Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)